Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ATNX

Athenex (ATNX) Stock Price, News & Analysis

Athenex logo

About Athenex Stock (NASDAQ:ATNX)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.20
$1.52
52-Week Range
N/A
Volume
1.88 million shs
Average Volume
194,316 shs
Market Capitalization
$1.76 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ATNX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Athenex and its competitors with MarketBeat's FREE daily newsletter.

ATNX Stock News Headlines

Protect Your Bank Account with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.
Athenex (NASDAQ: ATNX)
See More Headlines

ATNX Stock Analysis - Frequently Asked Questions

Athenex, Inc. (NASDAQ:ATNX) issued its quarterly earnings results on Thursday, November, 4th. The company reported ($0.33) earnings per share for the quarter, topping the consensus estimate of ($0.41) by $0.08. The company earned $32.30 million during the quarter, compared to analysts' expectations of $19.40 million. Athenex had a negative net margin of 86.31% and a negative trailing twelve-month return on equity of 727.79%.

Athenex (ATNX) raised $72 million in an initial public offering on Wednesday, June 14th 2017. The company issued 6,000,000 shares at $11.00-$13.00 per share. Credit Suisse, Deutsche, Bank Securities and J.P. Morgan acted as the underwriters for the IPO and ICBC International was co-manager.

Based on aggregate information from My MarketBeat watchlists, some other companies that Athenex investors own include TherapeuticsMD (TXMD), Meta Platforms (META), Sorrento Therapeutics (SRNE), NIO (NIO), NVIDIA (NVDA), Tesla (TSLA) and Ford Motor (F).

Company Calendar

Last Earnings
11/04/2021
Today
8/08/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:ATNX
CIK
1300699
Fax
N/A
Employees
652
Year Founded
2003

Profitability

EPS (Trailing Twelve Months)
($15.88)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$103.43 million
Net Margins
-86.31%
Pretax Margin
-95.92%
Return on Equity
-727.79%
Return on Assets
-44.44%

Debt

Debt-to-Equity Ratio
3.08
Current Ratio
1.09
Quick Ratio
0.72

Sales & Book Value

Annual Sales
$102.82 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($3.07) per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
8,660,000
Free Float
7,866,000
Market Cap
$1.76 million
Optionable
Optionable
Beta
1.36

Social Links

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NASDAQ:ATNX) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners